Adamantech

Adamantech was a U.S. private biotechnology company focused on perfluorocarbon-based formulations intended for therapeutic and diagnostic use. Its patent estate describes oxygen-carrying perfluoro compound dispersions and emulsions designed to sensitize hypoxic tumor cells to radiotherapy and chemotherapy, as well as related fluorocarbon purification, gel formulations, and X-ray contrast applications. The company appears to have operated primarily as a technology and intellectual-property holding entity rather than a developer of advanced clinical-stage products. Publicly available records indicate the company is inactive, with historical corporate ties to Delaware and Pennsylvania. Based on the available evidence, Adamantech did not progress to a marketed product or visible modern clinical pipeline.